Home

Todd Shegog

CIK 1714564 · SVP, Chief Financial Officer · last filed 2026-06-11

Todd Shegog is a SVP, Chief Financial Officer who has filed 14 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for COGT, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$55.6K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

14

Lifetime Open-Market Net

-$55.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
COGT Director — $34.68 — $0 7 2026-06-11
Forma Therapeutics Holdings, Inc. (FMTX) Delisted SVP, Chief Financial Officer 0 $20.01 $0 -$55.6K 5 2022-10-14
SYNLOGIC, INC. (SYBX) Delisted See Remarks — $0.69 — $0 2 2019-03-06

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-11 COGT Grant (A) — $0 EDGAR
2025-06-05 COGT Grant (A) — $0 EDGAR
2024-06-13 COGT Grant (A) — $0 EDGAR
2023-06-08 COGT Grant (A) — $0 EDGAR
2022-10-14 Forma Therapeutics Holdings, Inc. (FMTX) Delisted Mixed −56,143 $0 EDGAR
2022-06-09 COGT Grant (A) — $0 EDGAR
2022-03-02 Forma Therapeutics Holdings, Inc. (FMTX) Delisted Grant (A) +33,330 $0 EDGAR
2022-02-25 Forma Therapeutics Holdings, Inc. (FMTX) Delisted Sell (S) −5,687 -$55.6K EDGAR
2021-03-15 COGT Grant (A) — $0 EDGAR
2021-03-02 Forma Therapeutics Holdings, Inc. (FMTX) Delisted Grant (A) +28,500 $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.